Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?
- PMID: 22297819
- PMCID: PMC3277217
- DOI: 10.1038/mt.2011.288
Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical